Sigma Planning »

Cognition Therapeutics shares owned by Sigma Planning

Quarter-by-quarter ownership of Cognition Therapeutics (CGTX) shares owned by Sigma Planning from 13F filings

Historical chart of Sigma Planning investment in Cognition Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cognition Therapeutics held by Sigma Planning consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cognition Therapeutics by Sigma Planning

Quarter filed Position value Share count Share price at filing
2024-09-30 $92k 197k 0.47
2024-06-30 $286k 172k 1.66
2024-03-31 $290k 159k 1.82
2023-12-31 $53k 29k 1.85

More positions owned by Sigma Planning

Ishares Tr Core S&p500 Etf (IVV)
Apple (AAPL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr S&p 500 Grwt Etf (IVW)
Ishares Tr Core Div Grwth (DGRO)
Ishares Tr Iboxx Inv Cp Etf (LQD)
Pacer Fds Tr Us Cash Cows 100 (COWZ)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Alphabet Cap Stk Cl C (GOOG)
Schwab Strategic Tr Us Dividend Eq (SCHD)

View all positions for Sigma Planning

Top funds holding Cognition Therapeutics

Vanguard Group
Alyeska Investment Group
Geode Capital Management
CM Management
American Financial Group
Sigma Planning
Kestra Advisory Services
BlackRock
BlackRock
Acadian Asset Management
Mercer Global Advisors
Commonwealth Equity Services
Renaissance Technologies
Bridgeway Capital Management
State Street Corporation

View all funds holding Cognition Therapeutics